内脂素对ii型糖尿病模型小鼠病理发展的长期影响-中国试验动物学报.doc

内脂素对ii型糖尿病模型小鼠病理发展的长期影响-中国试验动物学报.doc

  1. 1、本文档共20页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
周传农修改英文摘要已修改正文中的英文书写已顺图的英文已顺文献的英文书写已顺小鼠表型特征与内脂素表达关菲菲全雄志张连峰摘要目的内脂素是近年发现的一种在内脏脂肪的因子研究表明胰岛素抵抗关键词内脂素转基因小鼠型糖尿病胰岛素耐受中图分类号文献标识码文章编号作者简介关菲菲女助理研究员博士主要研究方向代谢病动物模型基金资助国家科技支撑计划课题和国家重大新药创新科技重大专项课题引言近年来全球糖尿病内脂素是一种在内脏脂肪的因子研究表明胰岛素抵抗和且独立于胰岛素抵抗由以上研究结果发现与型糖尿病的关系尚未有一致的结

周传农修改: 英文摘要 — 已修改 正文中的英文书写 — 已顺 图的英文 — 已顺 文献的英文书写 — 已顺 Tg-visfatin×ob/ob小鼠表型特征与内脂素表达 关菲菲,全雄志,张连峰* [摘要] 目的 内脂素(visfatin )是近年发现的一种在内脏脂肪的因子,研究表明胰岛素抵抗。 [关键词]: 内脂素; 转基因; ob/ob小鼠; 2型糖尿病; 胰岛素耐受 [中图分类号] [文献标识码] [文章编号] Phenotypic characteristics and visfatin expression in Tg-visfatin×ob/ob mice GUAN Fei-fei, QUAN Xiong-zhi, GAO Shan, ZHANG Xiao-juan, GE Wen-ping, ZHANG Lian-feng* (Institute of Laboratory Animal Sciences, Peking Union Medical College Chinese Academy of Medical Sciences, Key Laboratory of Human Disease Comparative Medicine, Minstry of Health, Beijing 100021, China) [Abstract] Objective Visfatin is an adipokine associated with insulin resistance and type 2 diabetes (T2D). However, its effects are controversial in published reports. The aim of the present study was to determine the phenotypic characteristics of Tg-visfatin×ob/ob mice and explore the effect of visfatin on Tg-visfatin mice and type 2 diabete mice ob/ob. Methods Tg-visfatin mice were crossed with ob(+/?)mice to produce homozygote Tg-visfatin×ob/ob mice and ob/ob mice. The body weight of the two types of mice were recorded from 1 to 9 months of age. Intraperitoneal glucose tolerance test (IPGTT) and insulin tolerance test (ITT) were made at 3-, 5-, and 9-month-old mice, and the death rate of the mice were recorded from 9 to 11 month of age. Results The body weight from 1 to 9 months of age was almost the same. From the results of IPGTT and ITT, compared with ob/ob mice, at 3 months of age, the glucose tolerance and insulin tolerance of Tg-visfatin×ob/ob mice was reduced; at 5 months of age, only glucose tolerance of Tg-visfatin×ob/ob mice was reduced; when at 9 months of age, the glucose tolerance and insulin tolerance of Tg-visfatin×ob/ob mice was aggravated. The death rate of Tg-visfatin×ob/ob mice was improved by 44.4% than that of ob/ob mice from 9 to 11 months of age. Conclusions The results demonstrate that visfatin plays a positive role in attenuating glucose tolerance and insulin toler

文档评论(0)

wangsux + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档